The Competition Bureau's submission to support Health Canada's legislative review of the Cannabis Act investigates the competitive dynamics of cannabis industry
A recent decision by the Ontario Court of Appeal provides more guidance on good faith.
We look at the recent market analysis of the Canadian cannabis industry and challenges in cannabis restructuring.
Securities regulators provided guidance regarding disclosure of financial interests and conflicts of interest in Cannabis transactions
The Supreme Court of Newfoundland and Labrador (“Supreme Court”) has issued an important decision about the limits of accommodating the use of medically prescribed cannabis by an employee working in a safety-sensitive position.
On June 14, 2019, Health Canada unveiled its Final Regulations for New Cannabis Products
Regulation of CBD in the United States – Balancing Public Safety and Social Considerations with Industry Expectations and Consumer DemandJun 16, 2019
CBD (cannabidiol) is currently an industry hot topic.
Whether you are new to the cannabis industry, interested in starting a cannabis business, or have been seizing opportunities for a while — join us for an interactive day on the strategic and legal implications of the legalization of cannabis in Canada.
On October 10, 2018, the Canadian Securities Administrators published CSA Staff Notice 51-357, reviewing disclosure practices, deficiencies and best practices.
Get updates delivered right to your inbox. You can unsubscribe at any time.